Akriveia Therapeutics' Series A Round

Akriveia Therapeutics raised a round of funding on June 15, 2016. Investors include F-Prime Capital.

Akriveia Therapeutics is pursuing the discovery and development of next generation cancer immunotherapies. Akriveia believes its new agents offer the promise of a more efficacious and safer approach t…

Articles about Akriveia Therapeutics' Series A Round: